Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Retained Earnings (2010 - 2026)

Omeros (OMER) posted Retained Earnings of $793.6 million for Q1 2026, up 186.85% sequentially from -$913.7 million in Q4 2025, and up 8.76% YoY from $729.7 million in Q1 2025.

Analysis

Omeros (OMER) Retained Earnings (2010 - 2026) Analysis & Trends

Omeros has reported Retained Earnings for 17 years, with the latest figure at $793.6 million in Q1 2026.

  • Quarterly Retained Earnings rose 8.76% year-over-year to $793.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $793.6 million (up 8.76% YoY) and the FY2025 annual result came in at -$913.7 million, changed 0.37% from the prior year.
  • Retained Earnings grew to $793.6 million in Q1 2026 per OMER's latest filing, from -$913.7 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $793.6 million in Q1 2026 and troughed at -$969.2 million in Q2 2025.
  • A 5-year average of -$427.3 million and a median of -$744.5 million in 2023 frame the typical range for Retained Earnings.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings jumped 214.51% in 2023, then slumped 225.06% in 2024.
  • Over 5 years, Retained Earnings stood at -$635.7 million in 2022, then surged by 214.51% to $727.9 million in 2023, then plunged by 225.06% to -$910.3 million in 2024, then slipped by 0.37% to -$913.7 million in 2025, then surged by 186.85% to $793.6 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $793.6 million, -$913.7 million, and $779.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn -844.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -844.40 Mn
Mar 31, 2026 -857.64 Mn
Dec 31, 2025 -913.70 Mn
Sep 30, 2025 -1.00 Bn
Jun 30, 2025 -969.23 Mn
Mar 31, 2025 -943.81 Mn
Dec 31, 2024 -910.35 Mn
Sep 30, 2024 -878.99 Mn
Jun 30, 2024 -846.76 Mn
Mar 31, 2024 -790.71 Mn
Dec 31, 2023 -753.53 Mn
Sep 30, 2023 -744.46 Mn
Jun 30, 2023 -706.71 Mn
Mar 31, 2023 -669.42 Mn
Dec 31, 2022 -635.72 Mn
Sep 30, 2022 -764.45 Mn
Jun 30, 2022 -746.99 Mn
Mar 31, 2022 -716.15 Mn
Dec 31, 2021 -683.13 Mn
Sep 30, 2021 -963.76 Mn